Where does the development of new antituberculotics aim at?

Abstract

Several research teams in the Czech and Slovak Republics are oriented on the development of new antitubeculotics. The present article is based mainly on the information from the Chemical Abstracts from the year 2011 and the beginning of the year 2012.

It is a selection from almost three thousand reports aiming to help our scientists. The article presents topical information which may be of interest to several pharmaceutical professions.

Keywords

• Mycobacterium tuberculosis
• antituberculotics
• multiresistant mycobacteria
• QSAR
• evaluation in vivo
• biochemistry of mycobacteria